We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Product News

Product News

Eppendorf Donates 20,000 Euros to the EMBL to Promote Women Working in Science

Eppendorf SE has donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields.
Product News

Chan Zuckerberg Initiative Awards Two Grants to BrainGlobe

BrainGlobe, an open-source, community-driven platform for computational neuroanatomy, has been awarded two grants from the Chan Zuckerberg Initiative (CZI).
Product News

Blackrock Neurotech’s MoveAgain Brain-Computer Interface System Receives Breakthrough Device Designation from the FDA

Blackrock Neurotech has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its groundbreaking MoveAgain Brain Computer Interface (BCI) System.
Product News

Research on Hunger Wins 2021 Eppendorf & Science Prize

The American scientist Amber L. Alhadeff, Ph.D., Principal Investigator at the Monell Chemical Senses Center and the University of Pennsylvania, USA has won the 2021 Eppendorf & Science Prize for Neurobiology for her work on the gut-brain control of hunger circuits.
Product News

Ferrer and Treeway Enter Into Licence Agreement for the Development and Commercialisation of TW001/FNP122 for Amyotrophic Lateral Sclerosis

Ferrer and Treeway have announced they have entered into a license agreement for the development and commercialization of an oral formulation of edaravone for Amyotrophic Lateral Sclerosis.
Product News

Cognetivity Neurosciences Granted FDA Clearance for Commercial Distribution of ICA Throughout US Healthcare Market

Cognetivity Neurosciences Ltd. has announced that it has received notification from the US Food and Drug Administration (FDA) that its 510(k) submission for the CognICA Integrated Cognitive Assessment (ICA) has been reviewed and found to meet the requirements of regulations 21 CFR 882.1470; Class II Exempt Medical Device.
Product News

Cognetivity Neurosciences Granted FDA Clearance for Commercial Distribution of ICA Throughout US Healthcare Market

Cognetivity Neurosciences today announced that it has received notification from the US Food and Drug Administration (FDA) that itssubmission for the CognICA Integrated Cognitive Assessment (ICA) has been reviewed and found to meet medical device requirements.
Product News

PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis

Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types.
Product News

Durham University’s New Enterprise Zone Opens its Doors at NETPark

Orbit, a new business accommodation space hosted by Durham University, has opened a new facility in NETPark, one of the UK’s leading science and technology parks.
Product News

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

Wesana Health announced its commitment to fund an initial US $1.5 million to assess the viability of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI).
Advertisement